학술논문
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study
Document Type
Article
Author
Source
In: European urology oncology . (European urology oncology, 1 August 2023, 6(4):437-446)
Subject
Language
English
ISSN
25889311